Biogen Common Stock Total Equity vs Property Plant And Equipment Gross Analysis
BIIB Stock | USD 217.81 0.25 0.11% |
Biogen financial indicator trend analysis is way more than just evaluating Biogen Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biogen Inc is a good investment. Please check the relationship between Biogen Common Stock Total Equity and its Property Plant And Equipment Gross accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
Common Stock Total Equity vs Property Plant And Equipment Gross
Common Stock Total Equity vs Property Plant And Equipment Gross Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biogen Inc Common Stock Total Equity account and Property Plant And Equipment Gross. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Biogen's Common Stock Total Equity and Property Plant And Equipment Gross is -0.65. Overlapping area represents the amount of variation of Common Stock Total Equity that can explain the historical movement of Property Plant And Equipment Gross in the same time period over historical financial statements of Biogen Inc, assuming nothing else is changed. The correlation between historical values of Biogen's Common Stock Total Equity and Property Plant And Equipment Gross is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Total Equity of Biogen Inc are associated (or correlated) with its Property Plant And Equipment Gross. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant And Equipment Gross has no effect on the direction of Common Stock Total Equity i.e., Biogen's Common Stock Total Equity and Property Plant And Equipment Gross go up and down completely randomly.
Correlation Coefficient | -0.65 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Common Stock Total Equity
The total value of common stock equity held by shareholders, representing their ownership interest in the company.Property Plant And Equipment Gross
Most indicators from Biogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biogen Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. At present, Biogen's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 17.67, whereas Tax Provision is forecasted to decline to about 128.5 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 8.9B | 7.9B | 7.3B | 3.9B | Total Revenue | 11.0B | 10.2B | 9.8B | 10.3B |
Biogen fundamental ratios Correlations
Click cells to compare fundamentals
Biogen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Biogen fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 27.2B | 24.6B | 23.9B | 24.6B | 26.8B | 28.2B | |
Short Long Term Debt Total | 6.4B | 7.8B | 7.6B | 6.6B | 7.3B | 7.7B | |
Other Current Liab | 3.4B | 3.3B | 3.3B | 2.8B | 838.4M | 969.8M | |
Total Current Liabilities | 4.9B | 3.7B | 4.3B | 3.3B | 3.4B | 3.6B | |
Total Stockholder Equity | 13.3B | 10.7B | 11.0B | 13.4B | 14.8B | 15.5B | |
Property Plant And Equipment Net | 3.7B | 3.8B | 3.8B | 3.7B | 3.7B | 3.9B | |
Net Debt | 3.5B | 6.5B | 5.3B | 3.2B | 6.3B | 6.6B | |
Retained Earnings | 16.5B | 14.0B | 13.9B | 16.5B | 17.6B | 18.5B | |
Cash | 2.9B | 1.3B | 2.3B | 3.4B | 1.0B | 723.1M | |
Non Current Assets Total | 18.9B | 17.7B | 16.0B | 14.8B | 20.0B | 21.0B | |
Non Currrent Assets Other | (3.2B) | (1.4B) | 1.9B | 1.5B | 284.3M | 270.1M | |
Cash And Short Term Investments | 4.5B | 2.6B | 3.8B | 4.9B | 1.0B | 1.5B | |
Net Receivables | 1.9B | 1.9B | 1.5B | 2.1B | 2.1B | 2.2B | |
Common Stock Shares Outstanding | 187.4M | 161.3M | 149.6M | 146M | 145.6M | 283.0M | |
Liabilities And Stockholders Equity | 27.2B | 24.6B | 23.9B | 24.6B | 26.8B | 28.2B | |
Non Current Liabilities Total | 9.0B | 10.2B | 8.6B | 7.9B | 8.6B | 9.0B | |
Other Current Assets | 1.2B | 1.3B | 1.2B | 1.4B | 1.2B | 1.2B | |
Other Stockholder Equity | (3.0B) | (3.0B) | (2.8B) | (2.9B) | (2.7B) | (2.5B) | |
Total Liab | 13.9B | 13.9B | 12.9B | 11.2B | 12.0B | 12.6B | |
Property Plant And Equipment Gross | 3.7B | 3.8B | 3.8B | 3.7B | 6.1B | 6.4B | |
Total Current Assets | 8.4B | 6.9B | 7.9B | 9.8B | 6.9B | 7.2B | |
Accumulated Other Comprehensive Income | (135.2M) | (299M) | (106.7M) | (164.9M) | (153.7M) | (146.0M) | |
Intangible Assets | 3.5B | 3.1B | 2.2B | 1.9B | 8.4B | 8.8B | |
Accounts Payable | 530.8M | 454.9M | 589.2M | 491.5M | 403.3M | 423.5M | |
Short Term Investments | 2.3B | 1.6B | 1.3B | 1.5B | 1.5B | 0.0 | |
Inventory | 804.2M | 1.1B | 1.4B | 1.3B | 2.5B | 2.7B | |
Other Liab | 4.2B | 2.4B | 2.0B | 1.3B | 1.5B | 969.6M | |
Other Assets | 3.2B | 4.2B | 3.4B | 1.7B | 1.9B | 2.0B | |
Long Term Debt | 4.5B | 7.4B | 6.3B | 6.3B | 6.8B | 7.1B | |
Property Plant Equipment | 3.2B | 3.4B | 3.4B | 3.3B | 3.8B | 2.1B | |
Good Will | 5.8B | 5.8B | 5.8B | 5.7B | 6.2B | 3.2B | |
Net Tangible Assets | 4.1B | 1.9B | 2.9B | 5.8B | 6.7B | 4.1B | |
Noncontrolling Interest In Consolidated Entity | (4.1M) | (14.2M) | 63.5M | (9.5M) | (8.6M) | (8.1M) | |
Retained Earnings Total Equity | 16.5B | 14.0B | 13.9B | 16.5B | 18.9B | 11.5B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.MSFT | Microsoft | |
GM | General Motors | |
CRM | Salesforce |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Biogen Stock analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is Biogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.011 | Earnings Share 7.99 | Revenue Per Share 66.688 | Quarterly Revenue Growth (0.07) | Return On Assets 0.0486 |
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.